SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH)

34 filings reported holding SOPH - SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share as of Q2 2024.
SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17.9M shares of 66.4M outstanding shares and own 26.98% of the company stock.
Largest 10 shareholders include GENERATION INVESTMENT MANAGEMENT LLP (6.79M shares), UBS ASSET MANAGEMENT AMERICAS LLC (2.22M shares), BANQUE PICTET & CIE SA (2.2M shares), AKRE CAPITAL MANAGEMENT LLC (1.92M shares), Alta Wealth Advisors LLC (1.41M shares), PRINCIPAL FINANCIAL GROUP INC (1.37M shares), MILLENNIUM MANAGEMENT LLC (663K shares), ESSEX INVESTMENT MANAGEMENT CO LLC (305K shares), Bank Pictet & Cie (Europe) AG (223K shares), and EDMOND DE ROTHSCHILD HOLDING S.A. (203K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.